NovoCure (NVCR) Gross Profit Growth (3y) (2017 - 2026)
NovoCure (NVCR) Gross Profit Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.15% |
| 10 | NovoCure | 1.97 Bn | 1.53 Bn | 142.48 Mn | 15.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.68% |
| Mar 31, 2026 | 13.44% |
| Dec 31, 2025 | 9.92% |
| Sep 30, 2025 | 6.55% |
| Jun 30, 2025 | 1.45% |
| Mar 31, 2025 | 1.98% |
| Dec 31, 2024 | 7.27% |
| Sep 30, 2024 | 5.01% |
| Jun 30, 2024 | 3.32% |
| Mar 31, 2024 | -1.09% |
| Dec 31, 2023 | -4.39% |
| Sep 30, 2023 | -2.98% |
| Jun 30, 2023 | 0.58% |
| Mar 31, 2023 | 6.18% |
| Dec 31, 2022 | 10.17% |
| Sep 30, 2022 | 13.55% |
| Jun 30, 2022 | 19.64% |
| Mar 31, 2022 | 27.09% |
| Dec 31, 2021 | 30.44% |
| Sep 30, 2021 | 31.18% |